Jennison Associates
EVH icon

Jennison Associates’s Evolent Health EVH Stock Holding History

Jennison Associates’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-646,806
Closed -$18.3M – 601
2024
Q3 		$18.3M Buy
646,806
+34,990
+6% +$902K 0.01% 352
2024
Q2 		$11.7M Buy
+611,816
New +$15.6M 0.01% 373
2017
Q4 		– Sell
-704,007
Closed -$12.5M – 661
2017
Q3 		$12.5M Buy
+704,007
New +$14.5M 0.01% 458
2015
Q3 		– Sell
-49,826
Closed -$972K – 739
2015
Q2 		$972K Buy
+49,826
New +$929K ﹤0.01% 680

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Jennison Associates's EVH Position: Q4 2024 in Review

Jennison Associates sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 646,806 shares — an estimated $18.3M sold.

Jennison Associates first reported a position in EVH in Q2 2015 and held it in 4 quarters. The position peaked at $18.3M in Q3 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Jennison Associates reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Jennison Associates sold 646,806 Evolent Health shares in Q4 2024, an estimated $18.3M.
  • Jennison Associates first reported a position in Evolent Health in Q2 2015 and held it in 4 quarters.
  • Jennison Associates's Evolent Health position peaked at $18.3M in Q3 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Jennison Associates's 13F filing for Q4 2024, filed 24 Jan 2025.